COZZOLINO, MARIO GENNARO
COZZOLINO, MARIO GENNARO
Dipartimento di Scienze della Salute
Dietary Phosphorus and Metabolic Health in CKD and ESKD
2025 A. Cupisti, D. Giannese, M. Cozzolino, V. Panichi, C. D'Alessandro, M. Gallieni
Vitamin D assay and supplementation: still debatable issues
2025 M. Plebani, M. Zaninotto, S. Giannini, S. Sella, M. Fusaro, G.L. Tripepi, M. Gallieni, M. Herrmann, M. Cozzolino
Autonomic Nervous System Dysregulation and Bone Health in Patients with CKD: Potential for Intervention
2025 C. Zoccali, M.G. Vervloet, P. Evenepoel, Z. Massy, M. Cozzolino, F. Mallamaci, E.D. Lederer, J.C. Andia, T.B. Drueke
The autonomic nervous system and bone health in chronic kidney disease
2025 C. Zoccali, M.G. Vervloet, P. Evenepoel, Z. Massy, M. Cozzolino, F. Mallamaci, E.D. Lederer, J.C. Andia, T.B. Drueke
Vitamin D: are all compounds equal?
2025 L. Magagnoli, M. Cassia, A. Galassi, P. Ciceri, E. Massò, R. Gelpi, J. Bover, M. Cozzolino
The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation – a European consensus statement
2025 H. Skou Jørgensen, M. Vervloet, E. Cavalier, J. Bacchetta, M. H de Borst, J. Bover, M. Cozzolino, A. Carina Ferreira, D. Hansen, M. Herrmann, R. de Jongh, S. Mazzaferro, M. Wan, R. Shroff, P. Evenepoel
High-phosphate Causes Endothelial Extracellular Matrix Calcification by Inducing Endothelial Cell Mesenchymal Transition and Osteoblastic Differentiation
2025 P. Ciceri, L. Artioli, M. Molinaro, M. Falleni, D. Tosi, C. Martinelli, N. Santo, O. Rondinone, M. Miozzo, P. Bianchi, U. Gianelli, L. Fontana, M. Cozzolino
Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, Current treatments and investigational drugs
2024 L. Magagnoli, P. Ciceri, M. Cozzolino
Inibitori dell’enzima prolil-idrossilasi del fattore inducibile da ipossia: una nuova terapia per l’anemia nei pazienti con insufficienza renale cronica
2024 A. Stucchi, L. Magagnoli, A. Cara, M. Cozzolino
Determinazione e supplementazione della vitamina D: come, a chi e perché
2024 M. Plebani, M. Zaninotto, S. Giannini, S. Sella, M. Fusaro, G. Tripepi, M. Gallieni, M. Herrmann, M. Cozzolino
The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort
2024 I. Baragetti, L. Del Vecchio, F. Ferrario, F. Alberici, A. Amendola, E. Russo, S. Ponti, A.M. Di Palma, A. Pani, C. Rollino, D. Giannese, G. Boscutti, A. Sorrentino, C. Colturi, G. Brunori, R. Lazzarin, F. Catapano, M. Cozzolino, S. Feriozzi, C. Pozzi
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association
2024 S. Stoumpos, K. Crowe, P. Sarafidis, J. Barratt, D. Bolignano, L. Del Vecchio, J. Małyszko, A. Więcek, A. Ortiz, M. Cozzolino
Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease : Results from the EQUAL Study
2024 L. Magagnoli, M. Cozzolino, M. Evans, F.J. Caskey, F.W. Dekker, C. Torino, M. Szymczak, C. Drechsler, M. Pippias, A. Vilasi, R.J. Janse, M. Krajewska, V.S. Stel, K.J. Jager, N.C. Chesnaye
Vitamin D assay and supplementation: still debatable issues
2024 M. Plebani, M. Zaninotto, S. Giannini, S. Sella, M. Fusaro, G. Tripepi, M. Gallieni, M. Herrmann, M. Cozzolino
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices
2024 M. Fusaro, S. Barbuto, M. Gallieni, A. Cossettini, G.V. Re Sartò, L. Cosmai, G. Cianciolo, G. La Manna, T. Nickolas, S. Ferrari, J. Bover, M. Haarhaus, C. Marino, M.C. Mereu, M. Ravera, M. Plebani, M. Zaninotto, M. Cozzolino, S. Bianchi, P. Messa, M. Gregorini, L. Gasperoni, C. Agosto, A. Aghi, G. Tripepi
Iron biology
2024 L. Del Vecchio, D. Girelli, F. Vinchi, M. Cozzolino, S. Elliott, P. B Mark, L. Valenti, C. Qian, Q. Guo, Z. Qian, P. Ciceri, F. Locatelli
Patient-specific multifactorial mortality risk assessment using classification and regression tree analysis in the context of ambulatory blood pressure monitoring
2024 B.T. Çetin, N.B. Hasbal, E. Cevik, O.E. Sahin, M. Akyol, Z. Kalay, D. Ucku, C. Tanriover, M. Güldan, L. Özbek, O. Memetoglu, M.E. Erden, S. Copur, I. Siriopol, D. Siriopol, P. Ciceri, M. Cozzolino, M. Kanbay
Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease—a comprehensive review from the ERA CKD-MBD working group
2024 M. Kanbay, S. Copur, L. Ozbek, A. Mutlu, D. Cejka, P. Ciceri, M. Cozzolino, M.L. Haarhaus
Regional Citrate Anticoagulation: A Tale of More Than Two Stories
2024 T. Demuynck, M. Grooteman, P. Ter Wee, M. Cozzolino, B. Meijers
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: an Italian multicenter prospective study
2024 S. Borrelli, C. Garofalo, G. Reboldi, A. Coppola, P. Chiodini, M. Simeoni, A. Mazzieri, L.D. Volpe, M. Gallieni, C. Zummo, S. Cottone, M. Ravera, F. Aucella, F. Aucella, G. Stallone, V. Gismondi, F. Alberici, M. Gregori, G. Castellano, S. Vettoretti, M. Cozzolino, C. Ruotolo, R. Minutolo, L. De Nicola